Rituximab Likely Raises Risk of Hospital Death in COVID-19 Patients Rituximab Likely Raises Risk of Hospital Death in COVID-19 Patients

In hospitalized COVID-19 patients on immunosuppressive therapy, only those taking rituximab had an increased risk of in-hospital death in a retrospective analysis.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Internal Medicine News Source Type: news